Clinical Trials Logo

Clinical Trial Summary

This is a prospective, randomized, parallel-group, treatment control trial with cross-over options performed at four sites. The purpose of this study is to assess the efficacy and safety of cryoablation therapy for the treatment of post mastectomy pain syndrome.


Clinical Trial Description

This is a prospective, randomized, parallel-group, treatment control trial with cross-over options performed at four sites. The purpose of this study is to assess the efficacy and safety of cryoablation therapy for the treatment of post mastectomy pain syndrome. Participants will be randomized to receive cryoablation or a therapeutic peripheral nerve block injection (tPNB). All participants will be evaluated at baseline and after treatment at 10 days, 90 days, and 180 days via clinical visits. The option to undergo cryoablation or tPNB will be offered to all participants at the end of the 90 day post-procedure assessment. Each subject that elects the crossover intervention will be assessed over the same time period and in an identical fashion to the initial intervention, including a final long term follow up (LTFU) assessment at 180 days post-cryoablation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03293940
Study type Interventional
Source Emory University
Contact
Status Completed
Phase N/A
Start date January 10, 2018
Completion date May 19, 2021

See also
  Status Clinical Trial Phase
Completed NCT03081286 - Treatment of Postmastectomy Pain Syndrome With Fat Grafting N/A